1887

Abstract

SUMMARY

Following footpad inoculation in mice, herpes simplex virus type 1 spreads along nerves to the spinal cord where a myelitis causes hind limb paralysis beginning on day 6. Neutralizing antibody effectively prevents this illness only if given within 72 h. We therefore studied the timing of blood-brain barrier (BBB) disruption relative to the appearance of virus and inflammatory cell infiltrates in the spinal cord. Virus was detectable in dorsal root ganglion and spinal cord explants by 48 h. By 72 h, mononuclear cell infiltrates were evident in the spinal cord. By day 4, high titres of virus were demonstrable in the spinal cord. On day 6 I-labelled IgG tracers penetrated the spinal cord BBB. In addition, using a passive transfer model, mice given neutralizing IgG completely cleared footpad virus within 72 h while brain virus titres were unaffected by IgG treatment up to day 7. These observations indicate that the BBB may prevent IgG-mediated virus clearance during the early stages of infection.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-64-9-1965
1983-09-01
2024-12-03
Loading full text...

Full text loading...

/deliver/fulltext/jgv/64/9/JV0640091965.html?itemId=/content/journal/jgv/10.1099/0022-1317-64-9-1965&mimeType=html&fmt=ahah

References

  1. Cook M. L., Stevens J. G. 1973; Pathogenesis of herpetic neuritis and ganglionitis in mice: evidence for intraaxonal transport of infection. Infection and Immunity 7:272–288
    [Google Scholar]
  2. Davis W. B., Taylor J. A., Oakes J. E. 1979; Ocular infection with herpes simplex virus type 1: prevention of acute herpetic encephalitis by systemic administration of virus-specific antibody. Journal of Infectious Diseases 140:534–540
    [Google Scholar]
  3. Forghani B., Klassen T., Baringer I. R. 1977; Radioimmunoassay of herpes simplex virus antibody: correlation with ganglionic infection. Journal of General Virology 36:371–375
    [Google Scholar]
  4. Kristensson K., Sourander P. 1969; Changes in vascular permeability of the central nervous system by experimental herpes simplex and vaccinia virus infections. Acta neuropathologica 14:38–51
    [Google Scholar]
  5. Mcclellan R. H., Goodpasture E. W. 1923; A method of demonstrating experimental gross lesions of the central nervous system. Journal of Medical Research 44:201–207
    [Google Scholar]
  6. McKendall R. R., Vogelzang N., Jackson G. G. 1974; Herpes virus latency in spinal ganglia of mice without illness. Proceedings of the Society for Experimental Biology and Medicine 146:1093–1096
    [Google Scholar]
  7. McKendall R. R., Klassen T., Baringer J. R. 1979; Host defenses in herpes simplex infections of the nervous system: effect of antibody on disease and viral spread. Infection and Immunity 23:305–311
    [Google Scholar]
  8. Nahmias A. J., Whitley R. J., Visintine A. N., Takei Y., Alford C. A. JR 1982; Herpes simplex virus encephalitis: laboratory evaluations and their diagnostic significance. Journal of Infectious Diseases 145:82–836
    [Google Scholar]
  9. Oakes J. E., Rosemond-Hornbeak H. 1978; Antibody-mediated recovery from subcutaneous herpes simplex virus type 2 infection. Infection and Immunity 21:489–495
    [Google Scholar]
  10. Oakes J. E., Davis W. B., Taylor J. A., Weppner W. A. 1980; Lymphocyte reactivity contributes to protection conferred by specific antibody passively transferred to herpes simplex infected mice. Infection and Immunity 29:642–649
    [Google Scholar]
  11. Olson L. C., Buescher E. L., Artenstein M. S., Parkman P. D. 1967; Herpesvirus infections of the human central nervous system. New England Journal of Medicine 277:1271–1277
    [Google Scholar]
  12. Worthington M., Conliffe M. A., Baron S. 1980; Mechanism of recovery from systemic herpes simplex virus infection. I. Comparative effectiveness of antibody and reconstitution of immune spleen cells in immunosuppressed mice. Journal of Infectious Diseases 142:163–172
    [Google Scholar]
/content/journal/jgv/10.1099/0022-1317-64-9-1965
Loading
/content/journal/jgv/10.1099/0022-1317-64-9-1965
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error